Trial Details

COMPLETED
Basic Information
Clinical ID c1706
Identifier NCT04818892
Trial Title Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD|Covid19 Vaccine
Interventions DIAGNOSTIC_TEST: Serological Assay for SARS-CoV-2
Participant Information
Sponsor University of Wisconsin, Madison
City Madison
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2021-03-26
Primary Completion Date 2022-11-11
Completion Date 2022-11-11